Buy Ketorolac Tromethamine (Acular, Toradol) tablets and eye drops online ggstem
How and where to order Acular (Ketorolac) 0.4% 5 ml bottles eye drops, and Toradol (Ketorolac) 10 mg tablets online:
: CHEAP MEDS FOR SALE
: DFH PHARMACY
: PHARMA DOCTOR
Prices: from $0.34 per pillfrom $6.99 per bottle
Discount: 5% coupon for eye drops: 5OFF5% coupon for tablets: DFHDCC
Forms: Acular ophthalmic solution 0.4% 5 ml bottleToradol tablets 10 mg
Quantity: 1-6 bottles30-360 pills
Type: Ketorolac brand, Acular generic, Toradol generic
Payment: Visa, Mastercard, AmEx, E-Check (ACH), Bitcoin
Delivery: Standard airmail and trackable courier service
Shipping: Worldwide, including USA, UK, Europe, Canada, Australia
Ketorolac (trade names include Toradol, Acular, Ketorol, Acularen, Acular-LS, Acuvail, Algikey, Apo-Ketorolac, Dolac, Dolak, Dolgenal, Ketanov, Ketlur, Keto, Ketorolac Teva, Lixidol, Notolac, Novo-Ketorolac, Oculac, Sprix, Syndol) is a non-steroidal anti-inflammatory drug (NSAID). This medication is from acetic acid derivatives and related substances (for systemic, oral usage) and non-steroids antiinflammatory agents (for ophthalmological usage) pharmacological groups. Ketorolac Tromethamine in tablets (Toradol, Ketorol) is indicated for the treatment of moderate to severe pain in adults, dysmenorrhea, idiopathic pericarditis, inflammation, after surgery (in a postoperative setting for the management of moderately severe acute pain that requires analgesia at the opioid level). This medicine is works by affecting some hormones which cause and propel inflammation and pain in the human body. Ketorolac in pills is used alone or in combination with other medications.
Ketorolac Tromethamine as an ophthalmic solution (Acular) is used to relieve the itching and burning of seasonal allergies. It is also prescribed to reduce swelling, pain, and burning or stinging after cataract surgery or corneal refractive surgery, corneal abrasions.
Bimatoprost (Lumigan, Careprost)
Salicylic Acid (Salvax)
Pharmacological and medical categories:
Heterocyclic acetic acid derivatives
Nonsteroidal anti-inflammatory drugs (NSAIDs)
Ophthalmic decongestants, anesthetics, anti-inflammatories
Pain relief medications
M - Musculo-skeletal system
M01 - Antiinflammatory and antirheumatic products
M01A - Antiinflammatory and antirheumatic products, non-steroids
M01AB - Acetic acid derivatives and related substances
M01AB15 - Ketorolac
S - Sensory organs
S01 - Ophthalmologicals
S01B - Antiinflammatory agents
S01BC - Antiinflammatory agents, non-steroids
S01BC05 - Ketorolac
Other disorders of eyelid - H02
Edema of right eye, unspecified eyelid - H02.843
Disorders of lens - H25-H28
Other disorders of eye and adnexa - H57
Unspecified disorder of eye and adnexa - H57.9
Ocular pain, unspecified eye - H57.10
Acute pericarditis - I30
Vasomotor and allergic rhinitis - J30
Dorsalgia - M54
Other soft tissue disorders, not elsewhere classified - M79
Pain and other conditions associated with female genital organs and menstrual cycle - N94
Dysmenorrhea, unspecified - N94.6
Pain, not elsewhere classified - R52
Injury of eye and orbit - S05
Injury of conjunctiva and corneal abrasion without foreign body, unspecified eye, initial encounter - S05.00XA
Burn and corrosion confined to eye and adnexa - T26
Burn of unspecified eye and adnexa, part unspecified, initial encounter - T26.40XA
Other postprocedural states - Z98
Cataract extraction status, unspecified eye - Z98.49
Indications and usage:
Acute pain in adult patients. Toradol (Ketorolac) oral tablets is indicated for the short-term ( >= 5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting. Therapy should always be initiated with IV or IM dosing of ketorolac tromethamine, and Toradol oral is to be used only as continuation treatment, if necessary.
The total combined duration of use of Toradol oral and ketorolac tromethamine is not to exceed 5 days of use because of the potential of increasing the frequency and severity of adverse reactions associated with the recommended doses. Patients should be switched to alternative analgesics as soon as possible, but Ketorolac tablets therapy is not to exceed 5 days.
Acular (Ketorolac) ophthalmic solution is a nonsteroidal, anti-inflammatory indicated for:
The treatment of inflammation following cataract surgery.
The temporary relief of ocular itching due to seasonal allergic conjunctivitis.
Toradol (Ketorolac) is contraindicated in patients with previously demonstrated hypersensitivity to ketorolac tromethamine. This medication is contraindicated in patients with active peptic ulcer disease, in patients with recent gastrointestinal bleeding or perforation and in patients with a history of peptic ulcer disease or gastrointestinal bleeding.
Toradol should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.
Hypersensitivity to any component of this product.
Dosage and administration:
Patients age 17 to 64: 20 mg PO once followed by 10 mg q4-6 hours prn not > 40 mg/day.
Patients age >= 65, renally impaired, and/or weight < 50 kg (110 lbs): 10 mg PO once followed by 10 mg q4-6 hours prn not > 40 mg/day.
Oral formulation should not be given as an initial dose.
Use minimum effective dose for the individual patient.
Do not shorten dosing interval of 4 to 6 hours
Total duration of treatment in adult patients: the combined duration of use of IV or IM dosing of ketorolac tromethamine and Toradol oral is not to exceed 5 days.
One drop of Acular (Ketorolac Tromethamine) should be applied to the affected eye(s) four times a day for relief of ocular itching due to seasonal allergic conjunctivitis.
For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of Acular should be applied to the affected eye four times daily beginning 24 hours after cataract surgery and continuing through the first 2 weeks of the postoperative period.
Dosage forms and strengths:
Toradol (Ketorolac Tromethamine) 10 mg oral tablets are round, white, film-coated, red printed tablets. There is a large T printed on both sides of the tablet, with TORADOL on one side, and ROCHE on the other, available in bottles of 100 tablets.
Acular (Ketorolac Tromethamine) ophthalmic solution containing 5 mg/mL ketorolac tromethamine, 10 mL size bottle filled with 5 mL of solution.
Symptoms and signs: symptoms following acute NSAID (including Ketorolac) overdoses are usually limited to lethargy, drowsiness, nausea, vomiting, and epigastric pain, which are generally reversible with supportive care. Gastrointestinal bleeding can occur. Hypertension, acute renal failure, respiratory depression and coma may occur, but are rare. Anaphylactoid reactions have been reported with therapeutic ingestion of NSAIDs, and may occur following an overdose.
Treatment: patients should be managed by symptomatic and supportive care following a NSAIDs overdose. There are no specific antidotes. Emesis and/or activated charcoal (60 g to 100 g in adults, 1 g/kg to 2 g/kg in children) and/or osmotic cathartic may be indicated in patients seen within 4 hours of ingestion with symptoms or following a large oral overdose (5 to 10 times the usual dose). Forced diuresis, alkalization of urine, hemodialysis or hemoperfusion may not be useful due to high protein binding. Single overdoses of Ketorolac Tromethamine have been variously associated with abdominal pain, nausea, vomiting, hyperventilation, peptic ulcers and/or erosive gastritis and renal dysfunction which have resolved after discontinuation of dosing.
Warnings and precautions:
Risk of bleeding
Risk during labor and delivery
Concomitant use with NSAIDs
Some special populations
Cross-sensitivity or hypersensitivity
Increased bleeding time due to interference with thrombocyte aggregation
Corneal effects including keratitis
Ketorolac Tromethamine tablets interact with: warfarin, digoxin, salicylate, and heparin, aspirin, diuretics, probenecid, lithium, methotrexate, ACE inhibitors, angiotensin II receptor antagonists, antiepileptic drugs, psychoactive drugs, pentoxifylline, nondepolarizing muscle relaxants, selective serotonin reuptake inhibitors (SSRIs).
Adverse reactions, side effects:
Adverse reaction rates increase with higher doses of Toradol (Ketorolac Tromethamine). Practitioners should be alert for the severe complications of treatment with Toradol, such as GI ulceration, bleeding and perforation, postoperative bleeding, acute renal failure, anaphylactic and anaphylactoid reactions and liver failure.
The most frequent adverse reactions reported by up to 40% of patients participating in clinical trials have been transient stinging and burning on instillation.
To report suspected adverse reactions, contact Allergan, Roche pharmaceutical companies or your local FDA.
Patient counseling information for Ketorolac ophthalmic solution:
Because of the known effects of prostaglandin-inhibiting drugs on the fetal cardiovascular system (closure of the ductus arteriosus), the use of Acular solution during late pregnancy should be avoided.
Because many drugs are excreted in human milk, caution should be exercised when Acular (Ketorolac Tromethamine) eye drops is administered to a nursing woman.
Safety and efficacy in pediatric patients below the age of 2 have not been established.
No overall clinical differences in safety or effectiveness have been observed between elderly and other adult patients.
Patient counseling information for Ketorolac Tromethamine eye drops:
Slow or delayed healing
Patients should be informed of the possibility that slow or delayed healing may occur while using nonsteroidal anti-inflammatory drugs (NSAIDs).
Avoiding contamination of the product
Patients should be instructed to avoid allowing the tip of the bottle to contact the eye or surrounding structures because this could cause the tip to become contaminated by common bacteria known to cause ocular infections. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.
Also, to avoid the potential for cross-contamination, the patient should be advised to use one bottle for each eye following bilateral ocular surgery. The use of the same bottle of topical eye drops for both eyes following bilateral ocular surgery is not recommended.
Contact lens wear
Patients should be advised that Acular solution should not be administered while wearing contact lenses.
Intercurrent ocular conditions reference
Patients should be advised that if they develop an intercurrent ocular condition (e.g., trauma or infection) or have ocular surgery, they should immediately seek their physicianís advice concerning the continued use of Acular (Ketorolac Tromethamine) eye drops.
Concomitant topical ocular therapy
Patients should be advised that if more than one topical ophthalmic medication is being used, the medicines should be administered at least 5 minutes apart.
C - Australia
C - United States (Risk cannot be ruled out)
Salts and other forms:
Synonyms, international and chemical names:
1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-
Cetorolaco de Trometamina
Brands, generics, trade names:
Acular - Allergan
Acularen - Allergan
Acular-LS - Allergan, DKSH, The Glory Medicina
Acuvail - Allergan
Algikey - Inkeysa
Apo-Ketorolac - Apotex
Burten - Chile Laboratorios
Celfax - Degort's Chemical
Cetorolac - Farma-APS Produtos Farmaceuticos, Generis Farmaceutica
Cetorolaco - EMS Industria Farmaceutica
Cetrolac - Genom Farmaceutica
Deocil - Diffucap-Chemobras Quim Farm
Dolac - Cadila Pharmaceuticals, Ethica Industri Farmasi, Syntex
Dolak - Especialidades Dollder
Dolak-SL - Especialidades Dollder
Dolgenal - Tecnofarma
Dolgenal Rapid - Tecnofarma
Dolikan - Collins Productos Farmaceuticos
Dolnix - Farmindustria
Doloket - FDC
Dolorex - Medco Laboratorio
Dolten - Pfizer
Esmisen - Senosiain Laboratorios
Hanalgeze - Hersil Laboratorios Industriales Farmaceuticos
Kemanat - Microsules Argentina
Ketalgin - Pharmstandard-Oktyabr, Pharmstandard-Leksredstva, Pharmstandard-Ufavita
Ketanov - Ranbaxy, Sel-J Pharma
Ketlur - Sun Pharmaceutical Industries
Keto - Cipla, Y.S.P. Industries
Ketogesic - Dexa Medica Pharm & Chem, DKSH
Ketorol - Dr. Reddy's Laboratories, BioSys
Ketorolac - Alcon, Fresenius, Hospira, Mylan, Pfizer, Sandoz, Teva, Wockhardt
Ketorolaco - Biosano Laboratorios, Genfar Laboratorios, Normon Laboratorios
Ketzy - Zee Laboratories
Kortezor - Biomedis International, United Laboratories
Lacomin - Best Laboratorios
Lixidol - Roche
Mavidol - Productos Mavi
Nomadol - Bago Laboratorios
Notolac - Novapharma
Novo-Ketorolac - Novopharm
Oculac - Svizera Healthcare, Maneesh Pharmaceuticals
Onemer-SL - Pisa Laboratorios
Ratio-Ketorolac - Ratiopharm
Remopain - Dexa Medica Pharm & Chem, Getz Brothers Philippines, Gracio Med Philippines, Shwe Yadanar Myay
Sprix - Egalet Corporation, Luitpold Pharmaceuticals, Roxro Pharma
Supradol - Liomont Laboratorios
Syndol - Roche
Taradyl - Roche
Toloran - Rayere Farmaceuticos
Tonum - Almirall
Topidol - Nufarindo Pharmaceutical Laboratories
Toradol - Roche
Tora-Dol - Roche, GlaxoSmithKline, Recordati, Syntex
Toradol I.M. - Roche
Toragesic - Novaquimica Sigma Pharma-Nature's Plus
Torolac - Lupin Pharmaceuticals, Micro Labs
Torvin - Torrent Pharmaceuticals
Xevolac - Novell Pharmaceutical Laboratories
APIs used in medicine in combinations with ketorolac:
Sodium Acetate Dibasic
Vitamin B1 (Thiamine Monohydrate)
Vitamin B6 (Pyridoxine Hydrochloride)
Vitamin B12 (Cyanocobalamin)
Here is a list of popular medications containing ketorolac as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:
|Trade name of the drug
||Pharmaceutical forms and doses
||Solution; Ophthalmic; Ketorolac Tromethamine 0.5%
||Allergan2Care4 MedicalAbdi Ibrahim IlacAlviaAxicorp PharmaBeragena ArzneimittelCC PharmaDKSHEmra-Med ArzneimittelEurim-PharmGerke PharmaGervasi FarmaciaIDS GroupKohlpharmaMaxim IntercontinentalThe Glory MedicinaZuellig Pharma
||Solution; Ophthalmic; Ketorolac Tromethamine 0.45%
||Injectable; Injection; Ketorolac Tromethamine 30 mg / mlSolution; Ophthalmic; Ketorolac Tromethamine 0.5%Tablets; Oral; Ketorolac Tromethamine 10 mg
||Injectable; Injection; Ketorolac Tromethamine 30 mg / mlTablets, Film-Coated; Oral; Ketorolac Tromethamine 10 mg
||Solution; Ophthalmic; Ketorolac Tromethamine. 0.5%
||Sun Pharmaceutical IndustriesAvesta
||Drops; Oral; Ketorolac Tromethamine 20 mg / mlInjectable; Injection; Ketorolac Tromethamine 10 mg / mlInjectable; Injection; Ketorolac Tromethamine 30 mg / mlTablets, Film-Coated; Oral; Ketorolac Tromethamine 10 mg
||Spray, Metered; Nasal; Ketorolac Tromethamine 15.75 mg / dose
||Egalet CorporationLuitpold PharmaceuticalsRoxro Pharma
||Injectable; Injection; Ketorolac Tromethamine 30 mg / mlTablets, Film-Coated; Oral; Ketorolac Tromethamine 10 mg
||Drops; Oral; Ketorolac Tromethamine 20 mg / mlInjectable; Injection; Ketorolac Tromethamine 10 mg / mlInjectable; Injection; Ketorolac Tromethamine 15 mg / mlInjectable; Injection; Ketorolac Tromethamine 30 mg / mlTablets, Film-Coated; Oral; Ketorolac Tromethamine 10 mg
||RocheAtnahs PharmaDKSHFirma Chun CheongSyntexZuellig Pharma
Ketorolac main article on Wikipedia: https://en.wikipedia.org/wiki/Ketorolac
Ketorolac compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Ketorolac
Ketorolac Tromethamine Hydrochloride compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Ketorolac-tromethamine
Ketorolac on DrugBank: https://go.drugbank.com/drugs/DB00465
Ketorolac Tromethamine on DrugBank: https://go.drugbank.com/salts/DBSALT001045
Ketorolac FAQ on MedlinePlus (revised 11/15/2020): https://medlineplus.gov/druginfo/meds/a693001.html
Ketorolac Injection FAQ on MedlinePlus (revised 11/15/2020): https://medlineplus.gov/druginfo/meds/a614011.html
Ketorolac Nasal Spray FAQ on MedlinePlus (revised 11/15/2020): https://medlineplus.gov/druginfo/meds/a611042.html
Ketorolac Ophthalmic FAQ on MedlinePlus (revised 01/15/2016): https://medlineplus.gov/druginfo/meds/a601241.html
Teva Ketorolac Tromethamine film-coated tablets drug label info on DailyMed (revised October 29, 2020): https://dailymed.nlm.nih.gov/dailymed/lookup...
Acular (Ketorolac Tromethamine) ophthalmic solution drug label info on DailyMed (revised September 1, 2010): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
Ketorolac for sale on Pharma Doctor (revised October 2021): https://pharma-doctor.com/ketorolac.html
Ketorolac containing drugs on Drugs-About.com: https://drugs-about.com/ing/ketorolac.html
Toradol (Ketorolac Tromethamine) 10 mg tablets official prescribing information and medication guide from the U.S. FDA (revised February 2013): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Ketorolac Tromethamine injection for IV/IM use official prescribing information and medication guide from the U.S. FDA (revised 12/2011): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Acular (Ketorolac Tromethamine) ophthalmic solution 0.5% official prescribing information from the U.S. FDA (revised 05/2012): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Acular LS (Ketorolac Tromethamine) ophthalmic solution 0.4% official prescribing information from the U.S. FDA (revised May 2003): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Acular (Ketorolac Tromethamine) ophthalmic solution 0.5% prescribing information from Allergan pharmaceutical company (revised 06/2012): https://media.allergan.com/actavis/actavis/media/...
Acular LS (Ketorolac Tromethamine) ophthalmic solution 0.4% prescribing information from Allergan pharmaceutical company (revised 06/2016): https://media.allergan.com/actavis/actavis/media/...
Toradol (Ketorolac Trometamol) tablets product information from GP2U TeleHealth (revised 03 February 2012): https://gp2u.com.au/static/pdf/T/TORADOL-PI.pdf
Acular (Ketorolac Trometamol) 0.5% eye drops, ophthalmic solution package information leaflet from Medicines.org.uk (revised 05/2018): https://www.medicines.org.uk/emc/files/pil.855.pdf
Revised: October 2021